Bob Rauker, CEO, Belluscura plc
LSEG’s Rhiannon Main speaks to Bob Rauker, Belluscura’s Chief Executive Officer, to discuss how the MedTech company’s impressive growth in treating COPD and lung diseases with its next-generation oxygen enrichment technologies.
Having seen an oversubscribed IPO in 2021, the conversation highlights the company’s journey since its formation; from the first product launch, to FDA approval, continuing innovation, and how listing on AIM enabled a successful raise and has unlocked new growth potential.
-
Bob Rauker, Chief Executive Officer, Belluscura plc
Bob is a senior management executive with a track record in the medical device sector. Over his career Bob has been involved in the valuation, acquisition and sale of multiple medical devices. Bob has served as Head of Medical Device & Life Sciences Group for Acacia Research Group (NASDAQ) in the role of SVP, where he built the medical device business to $30 million in revenue.Previously he served as global chief IP counsel for Synthes Inc. (SIX) and the Boston Scientific Corporation (NYSE) Endoscopy business, both multi-billion dollar companies, where he managed the medical products acquisition and licensing transactions along with other senior management roles.Bob has a bachelor’s degree in mechanical engineering and an MBA from the University of Massachusetts and a juris doctorate from the New Hampshire School of Law. Additionally he is a registered patent attorney, a named inventor on 13 patents and pending applications in the medical device sector and joint inventor of the X-PLO2R portable oxygen concentrator. Bob joined the Board in August 2016.
-
Rhiannon Main, Senior Primary Markets Business Development Associate - Americas, London Stock Exchange
In her role as a Senior Associate in the Primary Markets Business Development team for the Americas, Rhiannon looks to increase the profile of the London Stock Exchange in the region as well as supporting companies looking to list in London.Previously, Rhiannon was an Analyst in the Primary Markets Analytics team after joining LSEG on the 2018 Business Graduate Programme. Rhiannon holds a Masters Degree in Chemistry (MChem) from the University of Oxford.
